- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: 94-132
Total 738 results
-
Memorial Sloan Kettering Cancer CenterCompletedLangerhans Cell HistiocytosisUnited States
-
University of California, San FranciscoIncyte CorporationNot yet recruitingRuxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)Hemophagocytic LymphohistiocytosesUnited States
-
SynerGene Therapeutics, Inc.Completed
-
Resolve TherapeuticsCompletedSystemic Lupus ErythematosusUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedOvarian CancerUnited States
-
Resolve TherapeuticsNewcastle-upon-Tyne Hospitals NHS Trust; University Hospital BirminghamCompletedSjogren's SyndromeUnited Kingdom
-
Gilead SciencesApproved for marketingMetastatic Triple-Negative Breast Carcinoma
-
Resolve TherapeuticsCompletedSystemic Lupus ErythematosusUnited States
-
BayerCompleted
-
Memorial Sloan Kettering Cancer CenterAmgenCompletedIsolated Chemotherapy-induced ThrombocytopeniaUnited States
-
BayerRecruitingType 2 Diabetes Mellitus | Chronic Kidney DiseaseGermany, Japan
-
New York State Psychiatric InstituteBayer; National Institute on Aging (NIA)CompletedLate Onset Alzheimer DiseaseUnited States
-
BiocadCompleted
-
Resolve TherapeuticsActive, not recruitingPost-acute Corona Virus 19 (COVID-19) (Long COVID)United States
-
Trefoil Therapeutics, Inc.Completed
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Heart Failure | Heart Failure, Congestive
-
Henri Mondor University HospitalSFMUCompletedShock | Cardiac Arrest | Coma | Major Trauma | Respiratory DistressFrance
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Laval UniversityRecruitingRespiratory Failure | Oxygen ToxicityCanada
-
Aviragen TherapeuticsCompleted
-
Gilead SciencesCompletedCervical Cancer | Urinary Bladder Neoplasms | Small Cell Lung Cancer | Hepatocellular Carcinoma | Pancreatic Cancer | Esophageal Cancer | Ovarian Epithelial Cancer | Glioblastoma Multiforme | Gastric Adenocarcinoma | Triple Negative Breast Cancer | Endometrial Cancer | Non-small Cell Lung Cancer | Renal Cell Cancer and other conditionsUnited States
-
Shalvata Mental Health CenterAbarbanel Mental Health CenterCompletedNegative and Cognitive Symptoms in SchizophreniaIsrael
-
Merck Sharp & Dohme LLCCompletedHepatitis C Virus | Liver Fibrosis
-
University of LausanneCompletedObesity | Non-alcoholic Fatty Liver DiseaseSwitzerland
-
Yale UniversityGilead SciencesRecruitingEndometrial CarcinomaUnited States
-
Biota Pharmaceuticals, Inc.Completed
-
Gilead SciencesWithdrawnTriple-negative Breast Cancer
-
BiocadActive, not recruitingMultiple SclerosisRussian Federation
-
Charite University, Berlin, GermanyCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
BayerCompletedClinical PharmacologyGermany
-
Izmir Katip Celebi UniversityIzmir Can HospitalCompletedPain, Acute | ComfortTurkey
-
Istanbul Kültür UniversityMarmara University; Istanbul UniversityCompleted
-
Yale UniversityGilead SciencesRecruitingOvarian CarcinomaUnited States
-
Gilead SciencesParexel; IQVIA RDS (Shanghai) Co., Ltd.; Medidata Solutions; Q Squared Solutions...Active, not recruitingMetastatic Triple-negative Breast CancerChina
-
Monash UniversityCurtin University; Flinders University; Ambulance Victoria; SA Ambulance Service; St John Ambulance Australia (Western Australia)Unknown
-
Gilead SciencesActive, not recruitingMetastatic Solid TumorUnited States, Spain, France, Hong Kong, Australia, Belgium, Taiwan, Canada
-
UCB PharmaCompletedUnverricht-Lundborg DiseaseUnited States, Canada, Finland, France, Israel, Russian Federation, Serbia, Tunisia
-
Gilead SciencesRecruitingAdvanced Solid TumorsUnited States
-
Gilead SciencesRecruiting
-
Cairo UniversityCompleted
-
Gilead SciencesParexel; Iqvia Pty Ltd; Medidata SolutionsActive, not recruitingMetastatic Breast CancerKorea, Republic of, Taiwan, China
-
Gilead SciencesRecruitingLiver Failure | Advanced or Metastatic Solid TumorFrance, United States
-
Yale UniversityGilead SciencesRecruitingA Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical CancerCervical CancerUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Gilead SciencesRecruiting
-
Tehran University of Medical SciencesCompletedRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
Gilead SciencesRecruitingStudy of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors (ASCENT-J02)Advanced Solid Tumor | Metastatic Urothelial Cancer | Metastatic Triple-Negative Breast Cancer | HR+/HER2- Metastatic Breast CancerJapan
-
Universidad Nacional de TucumanCompleted
-
Gilead SciencesEnrolling by invitationMetastatic Solid TumorFrance, United States, Belgium
-
Barbara Ann Karmanos Cancer InstituteBristol-Myers SquibbCompletedStage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Stage II Bladder Urothelial Carcinoma AJCC v6 and v7United States